The mean serum IGFBP2 level of gastric cancer patients was significantly higher than that of healthy controls (805.23 ± 590.56 ng/ml vs. 459.61 ± 277.01 ng/ml; P < 0.001) (Figure 1A). Here, IGFBP2 is linked to gastric cancer.